(Q44157516)

30 November 2017

Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models (English)

1 reference

30 November 2017

4

Gillian M Tozer

1 reference

30 November 2017

Sally A Hill

1

1 reference

30 November 2017

David J Chaplin

series ordinal

2

1 reference

30 November 2017

Gemma Lewis

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

International Journal of Cancer

30 November 2017

1 reference

30 November 2017

102

1 reference

30 November 2017

70-74

1 reference

30 November 2017

1

1 reference

Anti-angiogenic agents: clinical trial design and therapies in development

30 November 2017

1 reference

Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs

21 January 2018

1 reference

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

21 January 2018

1 reference

The biology of the combretastatins as tumour vascular targeting agents

21 January 2018

1 reference

Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy.

21 January 2018

1 reference

Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide

21 January 2018

1 reference

Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors

21 January 2018

1 reference

Tumour radiosensitization by high-oxygen-content gases: influence of the carbon dioxide content of the inspired gas on PO2, microcirculatory function and radiosensitivity.

21 January 2018

1 reference

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours

21 January 2018

1 reference

Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues.

21 January 2018

1 reference

Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy

21 January 2018

1 reference

Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines

21 January 2018

1 reference

Vinca alkaloids: anti-vascular effects in a murine tumour

21 January 2018

1 reference

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

Combretastatin A-4 prodrug inhibits growth of human non-small cell lung cancer in a murine xenotransplant model

21 January 2018

1 reference

Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10655

1 reference

30 November 2017

1 reference